Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124649943 | 12464994 | 3 | F | 2016 | 20160725 | 20160614 | 20160802 | EXP | CA-ABBVIE-16K-028-1642824-00 | ABBVIE | 68.59 | YR | F | Y | 104.60000 | KG | 20160802 | MD | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124649943 | 12464994 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | 6059356 | 125057 | SOLUTION FOR INJECTION IN PRE-FILLED PEN | ||||||||
| 124649943 | 12464994 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Y | 6059356 | 125057 | ||||||||||
| 124649943 | 12464994 | 3 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | U | UNKNOWN | 0 | 500 | MG | BID | ||||||
| 124649943 | 12464994 | 4 | SS | NAPROXEN. | NAPROXEN | 1 | U | UNKNOWN | 0 | ||||||||||
| 124649943 | 12464994 | 5 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | .112 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124649943 | 12464994 | 1 | Rheumatoid arthritis |
| 124649943 | 12464994 | 2 | Spondylitis |
| 124649943 | 12464994 | 3 | Rheumatoid arthritis |
| 124649943 | 12464994 | 4 | Spondylitis |
| 124649943 | 12464994 | 5 | Hypothyroidism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124649943 | 12464994 | OT |
| 124649943 | 12464994 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124649943 | 12464994 | Arthralgia | |
| 124649943 | 12464994 | Arthritis | |
| 124649943 | 12464994 | Atrial fibrillation | |
| 124649943 | 12464994 | Blood pressure abnormal | |
| 124649943 | 12464994 | Cardiac disorder | |
| 124649943 | 12464994 | Cardiac failure congestive | |
| 124649943 | 12464994 | Joint swelling | |
| 124649943 | 12464994 | Oedema | |
| 124649943 | 12464994 | Pain in extremity | |
| 124649943 | 12464994 | Peripheral swelling | |
| 124649943 | 12464994 | Peripheral venous disease | |
| 124649943 | 12464994 | Red blood cell sedimentation rate increased | |
| 124649943 | 12464994 | Stress | |
| 124649943 | 12464994 | Supraventricular extrasystoles | |
| 124649943 | 12464994 | Synovial cyst | |
| 124649943 | 12464994 | Synovial rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124649943 | 12464994 | 1 | 20160513 | 20160513 | 0 |